Evidence-Based TDM for Antiretroviral Drugs

Retrovirology - United Kingdom
doi 10.1186/1742-4690-7-s1-i11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hypersensitivity to Antiretroviral Drugs

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2018English

Safety of Antiretroviral Drugs

Arhiv za Farmaciju
PharmacologyPharmaceutical Science
2016English

Is HAART Based on Newest Active Antiretroviral Drugs Influenced by GSS?

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

HIV Patients Need New Antiretroviral Drugs

British Medical Journal
Medicine
2005English

Impact of Antiretroviral Drugs on the Microbiome

Current Opinion in HIV and AIDS
VirologyOncologyInfectious DiseasesImmunologyHematology
2018English

Molecular Mechanism of Potent Capsid-Targeting Antiretroviral Drugs

Biophysical Journal
Biophysics
2019English

International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Inhibition of Human Endogenous Retrovirus-K by Antiretroviral Drugs

Retrovirology
VirologyInfectious Diseases
2017English

HIV Infection-Associated Frailty: The Solution for Now Is Antiretroviral Drugs: A Perspective

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy